The expression of granulysin in systemic anaplastic large cell lymphoma in childhood.

[1]  B. Alisjahbana,et al.  Plasma granulysin levels and cellular interferon-gamma production correlate with curative host responses in tuberculosis, while plasma interferon-gamma levels correlate with tuberculosis disease activity in adults. , 2007, Tuberculosis.

[2]  A. Krensky,et al.  Granulysin-Mediated Tumor Rejection in Transgenic Mice1 , 2007, The Journal of Immunology.

[3]  K. Horibe,et al.  Recurrent childhood anaplastic large cell lymphoma: a retrospective analysis of registered cases in Japan , 2006, British journal of haematology.

[4]  A. Krensky,et al.  Coordinate Expression of CC Chemokine Ligand 5, Granulysin, and Perforin in CD8+ T Cells Provides a Host Defense Mechanism against Mycobacterium tuberculosis1 , 2005, The Journal of Immunology.

[5]  C. Meijer,et al.  Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas , 2004, Leukemia.

[6]  J. Whitin,et al.  Intracellular Mediators of Granulysin-Induced Cell Death 1 , 2003, The Journal of Immunology.

[7]  H. Shimada,et al.  Anaplastic large cell lymphoma in Japanese children: retrospective analysis of 34 patients diagnosed at the National Research Institute for Child Health and Development , 2003, British journal of haematology.

[8]  Jian Fei Wang,et al.  CD8 T Cell-Mediated Killing of Cryptococcus neoformans Requires Granulysin and Is Dependent on CD4 T Cells and IL-151 , 2002, The Journal of Immunology.

[9]  D. Newmeyer,et al.  A Distinct Pathway of Cell-Mediated Apoptosis Initiated by Granulysin1 , 2001, The Journal of Immunology.

[10]  T. Ganz,et al.  Granulysin, a T Cell Product, Kills Bacteria by Altering Membrane Permeability1 , 2000, The Journal of Immunology.

[11]  M. Werner,et al.  Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas , 2000, Leukemia.

[12]  A. Krensky,et al.  Bactericidal and Tumoricidal Activities of Synthetic Peptides Derived from Granulysin1 , 2000, The Journal of Immunology.

[13]  T. Ganz,et al.  An antimicrobial activity of cytolytic T cells mediated by granulysin. , 1998, Science.

[14]  A. Krensky,et al.  Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways. , 1998, Journal of immunology.

[15]  M. Seto,et al.  Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression. , 1997, The American journal of surgical pathology.

[16]  A. Krensky,et al.  Granulysin, a new human cytolytic granule-associated protein with possible involvement in cell-mediated cytotoxicity. , 1997, Seminars in immunology.

[17]  A. Krensky,et al.  Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. , 1997, Journal of immunology.

[18]  E. Jaffe,et al.  Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. , 1997, Blood.

[19]  H. Stein,et al.  Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. , 1996, Blood.

[20]  A. Krensky,et al.  Identification and molecular cloning of tactile. A novel human T cell activation antigen that is a member of the Ig gene superfamily. , 1992, Journal of immunology.

[21]  K. Lennert,et al.  The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. , 1985, Blood.

[22]  M. Walch,et al.  Cholesterol in Negatively Charged Lipid Bilayers Modulates the Effect of the Antimicrobial Protein Granulysin , 2006, The Journal of Membrane Biology.

[23]  T. Kishida,et al.  Differential expression of granulysin and perforin by NK cells in cancer patients and correlation of impaired granulysin expression with progression of cancer , 2001, Cancer Immunology, Immunotherapy.